AKIN GUMP STRAUSS HAUER & FELD for SUN PHARMA (FORMERLY RANBAXY INC )
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. No. 111-148, Patient Protection and Affordable Care; prescription drug user fee reauthorization issues; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality in Drug Compounding Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| CAITLIN SUZANNE MCCORMICK | — |
| MATTHEW TODD TUTEN | — |
| ANURAG VARMA | — |
Pharmacy PHA
S. 214, Preserve Access to Affordable Generics; implementation of P.L. No. 111-148, Patient Protection and Affordable Care Act; prescription drug user fee reauthorization issues; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| CAITLIN SUZANNE MCCORMICK | — |
| MATTHEW TODD TUTEN | — |
| ANURAG VARMA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.